
Vineet Laboratories (VINEETLAB) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
74.4M
Gross Profit
28.3M
38.03%
Operating Income
-3.1M
-4.13%
Net Income
-8.7M
-11.64%
EPS (Diluted)
₹-0.94
Balance Sheet Metrics
Total Assets
945.4M
Total Liabilities
798.9M
Shareholders Equity
146.5M
Debt to Equity
5.45
Cash Flow Metrics
Operating Cash Flow
-59.9M
Free Cash Flow
154.7M
Revenue & Profitability Trend
Vineet Laboratories Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 750.0M | 1.5B | 2.1B | 1.9B | 2.4B |
Cost of Goods Sold | 702.4M | 1.2B | 1.8B | 1.6B | 2.1B |
Gross Profit | 47.6M | 337.1M | 357.5M | 318.0M | 306.8M |
Gross Margin % | 6.3% | 22.4% | 16.8% | 16.6% | 12.6% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 34.9M | 40.4M | 24.0M | 6.5M |
Other Operating Expenses | 157.0M | 120.3M | 122.5M | 115.7M | 110.9M |
Total Operating Expenses | 157.0M | 155.1M | 162.9M | 139.7M | 117.5M |
Operating Income | -187.8M | 46.8M | 56.3M | 111.5M | 63.4M |
Operating Margin % | -25.0% | 3.1% | 2.7% | 5.8% | 2.6% |
Non-Operating Items | |||||
Interest Income | - | 354.0K | 1.2M | 1.6M | 462.0K |
Interest Expense | 39.8M | 38.5M | 26.6M | 14.9M | 20.6M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | -207.8M | 3.6M | 20.3M | 93.5M | 40.6M |
Income Tax | -5.8M | -6.6M | 7.8M | 27.1M | 22.8M |
Effective Tax Rate % | 0.0% | -182.6% | 38.3% | 29.0% | 56.1% |
Net Income | -201.9M | 10.3M | 12.5M | 66.4M | 17.8M |
Net Margin % | -26.9% | 0.7% | 0.6% | 3.5% | 0.7% |
Key Metrics | |||||
EBITDA | -143.0M | 63.7M | 70.6M | 128.5M | 79.2M |
EPS (Basic) | ₹-21.90 | ₹1.11 | ₹1.36 | ₹7.16 | ₹1.93 |
EPS (Diluted) | ₹-21.90 | ₹1.11 | ₹1.36 | ₹7.16 | ₹1.93 |
Basic Shares Outstanding | 9219635 | 9219008 | 9219008 | 9219008 | 9219008 |
Diluted Shares Outstanding | 9219635 | 9219008 | 9219008 | 9219008 | 9219008 |
Income Statement Trend
Vineet Laboratories Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 3.1M | 2.3M | 6.3M | 166.6M | 7.5M |
Short-term Investments | 3.6M | 2.7M | 3.2M | 14.6M | 13.5M |
Accounts Receivable | 132.5M | 316.0M | 351.6M | 362.0M | 427.1M |
Inventory | 499.7M | 493.9M | 461.7M | 435.4M | 396.9M |
Other Current Assets | 35.1M | 1.7M | 1.7M | 48.7M | -1.0K |
Total Current Assets | 673.9M | 881.9M | 874.6M | 1.0B | 863.6M |
Non-Current Assets | |||||
Property, Plant & Equipment | - | 18.3M | 18.1M | 18.0M | 17.6M |
Goodwill | - | - | - | 0 | 0 |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | 0 | 0 |
Other Non-Current Assets | 6.7M | 1.7M | 3.1M | 4.7M | - |
Total Non-Current Assets | 271.5M | 286.8M | 283.9M | 306.1M | 223.8M |
Total Assets | 945.4M | 1.2B | 1.2B | 1.3B | 1.1B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 336.1M | 322.6M | 348.9M | 600.9M | 559.9M |
Short-term Debt | 362.6M | 404.1M | 262.4M | 289.8M | 149.4M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 40.3M | 23.3M | 1.0K | -1.0K | - |
Total Current Liabilities | 743.9M | 760.0M | 745.1M | 947.7M | 746.5M |
Non-Current Liabilities | |||||
Long-term Debt | 37.9M | 38.9M | 48.5M | 17.2M | 34.7M |
Deferred Tax Liabilities | 9.1M | 14.6M | 20.5M | 17.9M | 22.7M |
Other Non-Current Liabilities | - | 2.0K | - | -1.0K | -2.0K |
Total Non-Current Liabilities | 55.0M | 61.5M | 76.6M | 53.3M | 74.8M |
Total Liabilities | 798.9M | 821.5M | 821.7M | 1.0B | 821.3M |
Equity | |||||
Common Stock | 92.2M | 92.2M | 92.2M | 92.2M | 92.2M |
Retained Earnings | - | 142.7M | 132.4M | 129.1M | 63.1M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 146.5M | 347.2M | 336.8M | 332.2M | 266.2M |
Key Metrics | |||||
Total Debt | 400.5M | 443.0M | 310.9M | 307.0M | 184.1M |
Working Capital | -70.0M | 121.9M | 129.5M | 79.4M | 117.1M |
Balance Sheet Composition
Vineet Laboratories Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -207.8M | 3.6M | 20.3M | 93.5M | 40.6M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | 0 | 0 |
Working Capital Changes | 224.7M | -110.7M | 114.5M | -84.8M | -765.6M |
Operating Cash Flow | 76.6M | -86.5M | 167.4M | 27.5M | -698.8M |
Investing Activities | |||||
Capital Expenditures | -10.5M | -2.3M | -76.3M | 0 | 0 |
Acquisitions | - | - | - | 0 | 0 |
Investment Purchases | - | - | 0 | -38.4M | -78.5M |
Investment Sales | - | - | 8.3M | 0 | 0 |
Investing Cash Flow | -12.0M | -1.3M | -68.1M | -38.4M | -78.5M |
Financing Activities | |||||
Share Repurchases | - | - | - | 0 | 0 |
Dividends Paid | - | - | -9.2M | - | - |
Debt Issuance | 2.0M | 51.9M | 41.7M | 140.4M | 124.7M |
Debt Repayment | -44.5M | -58.7M | 0 | 0 | 0 |
Financing Cash Flow | -80.7M | 132.1M | 36.5M | 140.4M | 212.8M |
Free Cash Flow | 104.5M | -116.6M | -172.5M | 76.3M | -87.1M |
Net Change in Cash | -16.1M | 44.3M | 135.8M | 129.5M | -564.5M |
Cash Flow Trend
Vineet Laboratories Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
316.25
Price to Book
2.30
Price to Sales
0.53
PEG Ratio
-5.33
Profitability Ratios
Profit Margin
-31.44%
Operating Margin
-3.88%
Return on Equity
-81.56%
Return on Assets
-10.05%
Financial Health
Current Ratio
0.91
Debt to Equity
285.88
Beta
-0.27
Per Share Data
EPS (TTM)
₹-20.53
Book Value per Share
₹15.00
Revenue per Share
₹65.32
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
vineetlab | 317.4M | 316.25 | 2.30 | -81.56% | -31.44% | 285.88 |
Navin Fluorine | 255.9B | 69.93 | 9.44 | 10.99% | 13.90% | 55.85 |
Deepak Nitrite | 253.2B | 41.67 | 4.70 | 11.85% | 7.58% | 23.36 |
India Glycols | 50.0B | 20.49 | 2.21 | 10.24% | 6.35% | 83.85 |
Styrenix Performance | 46.4B | 20.53 | 3.97 | 20.14% | 7.00% | 34.02 |
Gujarat Alkalies | 40.4B | 70.12 | 0.67 | -1.08% | -0.82% | 9.30 |
Financial data is updated regularly. All figures are in the company's reporting currency.